Cargando…

Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update

Patients with a hematological malignancy are a heterogeneous patient population who are afflicted with diseases that range from rapidly fatal acute leukemia to indolent lymphoma or chronic leukemia. Treatment options for these patients range from observation to hematopoietic stem cell transplantatio...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wade, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120157/ http://dx.doi.org/10.1007/978-1-4614-3764-2_52

Ejemplares similares

Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies
por: Yamamichi, Takashi, et al.
Publicado: (2018)

Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
por: Little, Jessica S., et al.
Publicado: (2021)

The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies
por: Daraskevicius, Justinas, et al.
Publicado: (2022)

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
por: Salih, Zena, et al.
Publicado: (2013)

New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies
por: Menzo, Sara Lo, et al.
Publicado: (2015)

Epidemiology and clinical manifestation of fungal infection related to Mucormycosis in hematologic malignancies
por: Noorifard, M, et al.
Publicado: (2015)

Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive
por: Spallone, Amy, et al.
Publicado: (2020)

Update on the role of copanlisib in hematologic malignancies
por: Le, Thuy, et al.
Publicado: (2021)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting
por: Li, Yangqiu
Publicado: (2012)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases
por: Leone, Giuseppe, et al.
Publicado: (2015)

Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations
por: Sipsas, Nikolaos V., et al.
Publicado: (2018)

Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study
por: Fracchiolla, Nicola Stefano, et al.
Publicado: (2019)

The DNA methylation landscape of hematological malignancies: an update
por: Blecua, Pedro, et al.
Publicado: (2020)

2019–2020 Drug Updates in Hematologic Malignancies
por: Finnes, Heidi D.
Publicado: (2021)

2018–2019 Drug Updates in Hematologic Malignancies
por: Held, Lauren
Publicado: (2020)

2020–2021 Drug Updates in Hematologic Malignancies
por: Hanna, Kirollos
Publicado: (2022)

2021–2022 Drug Updates in Hematologic Malignancies
por: Tobin, Jenni
Publicado: (2023)

Engineering naturally occurring CD7(−) T cells for the immunotherapy of hematological malignancies
por: Freiwan, Abdullah, et al.
Publicado: (2022)

Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies
por: Valković, Toni, et al.
Publicado: (2022)

Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice
por: Rambaldi, Benedetta, et al.
Publicado: (2017)

INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES – A FIVE-YEAR SINGLE CENTER EXPERIENCE
por: Buljan, Domagoj, et al.
Publicado: (2022)

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
por: Gamaletsou, Maria N., et al.
Publicado: (2018)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections
por: Xiao, Han, et al.
Publicado: (2020)

2100. Epidemiology and Risk Factors for Invasive Fungal Infections Among Patients with Hematological Malignancies In Colombia
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2022)

Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies
por: Li, Zengzheng, et al.
Publicado: (2021)

Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China
por: Zhang, Xiaohui, et al.
Publicado: (2018)

The Prevalence of fungal infections in children with hematologic malignancy in Ali-Asghar Children Hospital between 2005 and 2010
por: Ansari, Sh, et al.
Publicado: (2015)

CARD9 in host immunity to fungal, bacterial, viral, and parasitic infections: An update
por: Hu, Ang, et al.
Publicado: (2022)

2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy
por: Bold, Tyler D, et al.
Publicado: (2019)

Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy
por: Talebshoushtari Zadeh, Maryam, et al.
Publicado: (2022)

Assessment and Management of Cardiotoxicity in Hematologic Malignancies
por: Bojan, Anca, et al.
Publicado: (2021)

Evaluation of Infection Risk Factors in Adult Hematologic Malignancy Patients
por: Peterson, Shawn Lanham, et al.
Publicado: (2019)

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study
por: Maziarz, Richard T., et al.
Publicado: (2016)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients
por: Montagna, M. T., et al.
Publicado: (2013)

Massage for Symptom Management in Adult Inpatients With Hematologic Malignancies
por: Kuon, Carla, et al.
Publicado: (2019)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6bin5j13bi6tl9604iis8i40hv